Want show notes for this and earlier episodes? You'll find them here: peterottsjo.beehiiv.com/
I (Peter Ottsjö) started paying close attention to aging biology and longevity around ten years ago. At that time, in Sweden, it felt kinda lonely. There was no big sprawling community of longevity enthusiasts back then. That’s how it felt to me anyway.
But certain names consistently appeared in my research. One that stood out was Linus Petersson.
And he probably felt the same way. Linus Petersson, a technical biology engineer, has just recently co-founded of the Swedish Longevity Cluster and he’s on a mission to get as many people as possible interested in and working on the problem of solving aging.
And not only that, he’s also written a book that is coming out very soon. It’s called Läkemedel mot åldrande: Hur modern vetenskap ger oss obegränsad livslängd. In English that would translate to Medicine against aging: How modern science gives us unlimited lifespan.
In this episode, we dive deep into the world of longevity research. Linus brings a unique perspective to the field, combining his background in pharmaceutical development with a passionate advocacy for solving the problem of aging. We talk about the hallmarks of aging, drugs like rapamycin and metformin and cutting-edge approaches like growing non-sentient bodies for transplantation. He argues compellingly for classifying aging as a disease and offers insights into the economic and societal impacts of increased healthspans. Linus addresses common concerns like overpopulation and societal stagnation with data-driven responses. He also discusses the role of AI in longevity research and the urgent need for more talent and resources in the field. Whether you're a science enthusiast, a healthcare professional, or simply curious about the future of human longevity, this episode offers a fascinating glimpse into the forefront of anti-aging research.
I don't feel lonely anymore because the Swedish Longevity Cluster has not only brought together enthusiasts and researchers, but has also ignited a broader interest in longevity science across Sweden, creating the sprawling community I once yearned for. I am sure Linus would agree with me. But there is lots more work to do.
Hosted on Acast. See acast.com/privacy for more information.
